The Analyst Landscape: 6 Takes On PROCEPT BioRobotics
Media

The Analyst Landscape: 6 Takes On PROCEPT BioRobotics

Latest Ratings for PRCT

Date Firm Action From To
Mar 2022 B of A Securities Maintains Buy
Mar 2022 SVB Leerink Maintains Outperform
Nov 2021 SVB Leerink Maintains Outperform

View More Analyst Ratings for PRCT

View the Latest Analyst Ratings

read more

​ 

​Latest Ratings for PRCT
DateFirmActionFromTo Mar 2022B of A SecuritiesMaintainsBuy Mar 2022SVB LeerinkMaintainsOutperform Nov 2021SVB LeerinkMaintainsOutperform
View More Analyst Ratings for PRCT

View the Latest Analyst Ratings

read more 

Leave a Reply

Your email address will not be published. Required fields are marked *

This material is for informational purposes is not intended to be relied upon as a forecast, research or investment advice, and is not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. The opinions expressed are as of date of publication and are subject to change. Reliance upon information in this material is at the sole discretion of the reader. Past performance is not indicative of current or future results. This information provided is neither tax nor legal advice and investors should consult with their own advisors before making investment decisions. Investment involves risk including possible loss of principal.